Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by bartlmanon Jul 25, 2016 7:10pm
242 Views
Post# 25083219

Thoughts on the delay

Thoughts on the delaySo my thinking is that the delay has been caused not so much by looking for better and better ways to sterilize the equipment but in modifications to the design of the equipment such that sterilization is that much easier and less troublesome. That might mean more (or fewer...) pieces utilized in the design of the scope, elimination of troublesome junctions or interfaces betweeen components, new materials or whatever. It would have been nice to have had some indication as to what the company was indeed persuing during this time interval but it stretches credibility to think that this entire 6 weeks has been spent finding better ways to boil the stuff so that it is 100% pure and clean. So, I'm suggesting that design changes may be the cause for the delay plus additional testing to insure the new design passes the sterilization safety test. Otherwise they should just have gone with the old stuff on a disposable, one-time use basis as I proposed several weeks ago and worked on design modifications while initial human trials were ongoing.
Bullboard Posts